mots c 5 amino 1mq MOTS-C 10MG/5-Amino 10MG 5-Amino-1MQ - Research Peptide -

Unlike some weight-loss options that risk breaking down muscle, 5-Amino-1MQ supports muscle preservation while targeting fat

Products are not intended to diagnose, treat, cure, or prevent any disease

The molecule was developed by the Australian pharmaceutical company Metabolic Pharmaceuticals (in collaboration with Monash University) and advanced through Phase I safety trials and a Phase IIb obesity efficacy trial enrolling approximately 900 participants in total

This does not influence the clinical analysis

Publishing them would invite exactly the kind of unsupervised self-administration that makes investigational peptides dangerous